Med-tech firms raising money in public or private financings, including: Axogen

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hyperfine, Herowear, Kardium, Natera, Quanterix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axion Biosystems, Biotissue, Concept Medical, Cerus, Cytotronics, Integrity Orthopaedics, Qure.ai, Reflexion, Smith + Nephew, Spotitearly.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gore, Guardant Health, Horiba, Onemednet.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Akeso, Atossa, Bioxcel, Bpgbio, Capricor, Celcuity, Cogent, Daiichi, Dyne, Eli Lilly, Immunitybio, Iregene, Lantern, Mesoblast, Nanoscope, Novartis, Organon, Rein, Valneva.

Biopharma happenings, including deals and partnerships, and other news in brief: Aicuris, Alteogen, Aspect, Boundless Bio, GSK, Guardant Health, Hyloris, Merck, Novo Nordisk, Orion, Pfizer, Shionogi, Smartbax, Tesaro, Viiv.

Clinical updates, including data readouts and publications: Biovaxys, Corvus, Genmab, Moderna, Nasus, Nxera, Phio, Reunion.

Biopharmas raising money in public or private financings, including: Agomab, DBV, Harbour, Metavia, Spyglass.

New hires and promotions in the biopharma industry, including: Artcline, Emmecell, Nxera, Orikine, Taiho, Vaximm.

New hires and promotions in the med-tech industry, including: BrightInsight, BVI.